Altogether, the evidence that co-expression of the HBx and c-MYC transgenes accelerated HCC development in transgenic mice clearly establishes this viral transactivator as a tumor promoter, and as a cooperating partner of the c-MYC oncogene in liver cell transformation [30]. This evidence concerns the gene MYC and neoplasm.